20 May 2022 , 01:46 PM
Net profit of Gujarat Themis Biosyn rose 69.08% to Rs 9.79 crore in the quarter ended March 2022 as against Rs 5.79 crore during the previous quarter ended March 2021. Sales rose 23.43% to Rs 28.76 crore in the quarter ended March 2022 as against Rs 23.30 crore during the previous quarter ended March 2021. For the full year,net profit rose 44.53% to Rs 43.62 crore in the year ended March 2022 as against Rs 30.18 crore during the previous year ended March 2021. Sales rose 26.82% to Rs 114.85 crore in the year ended March 2022 as against Rs 90.56 crore during the previous year ended March 2021.
Particulars | Quarter Ended | Year Ended | ||||
? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
Sales | 28.76 | 23.30 | 23 | 114.85 | 90.56 | 27 |
OPM % | 45.48 | 35.62 | – | 50.54 | 44.53 | – |
PBDT | 14.41 | 8.81 | 64 | 61.26 | 42.62 | 44 |
PBT | 13.87 | 8.14 | 70 | 59.03 | 40.89 | 44 |
NP | 9.79 | 5.79 | 69 | 43.62 | 30.18 | 45 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.